| Tag | Content |
|---|
EnhancerAtlas ID | HS029-01297 |
Organism | Homo sapiens |
Tissue/cell | CUTLL1 |
Coordinate | chr1:206938870-206940890 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| PBX1 | MA0070.1 | chr1:206939368-206939380 | ACATCAATCAAT | + | 6.44 | | TCF7L2 | MA0523.1 | chr1:206939770-206939784 | TCGCTTTGATGTTT | - | 6.54 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_18640 | chr1:206938558-206940480 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19631 | chr1:206939257-206940450 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_61266 | chr1:206939355-206991151 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I206765 | chr1 | 206939241 | 206940345 |
|
Enhancer Sequence | GTTAGATTAT TAAATCCCAA TAAAGCAAAT GTAACAGAAA AAAATGACTA TCAGCTTCCT 60
CTTGGAGAAA ACAGCAATAA TGCCATCTTA TTGCTACATA ATACATACCA AATGGCTTAA 120
AATAAGTGAC TAGCTTAATA AACTGTAGTT GCTTAATAAA TTGTAGCTAT CATTAACATC 180
TTTTCAGCTG TACAGCTTTT TTTCAGGTGA GTTTCTGTTT GTTTCAGATG CCCACTTCGC 240
TCAGATGAAA TGCCAGGCTC AAACTAAAGT CAGTATGCAT TGCCTGGAAG GCTAATGGCC 300
TAAGCCTTCC AGGCCAGGGG ACTTGTGAAC CCTGAAAATT TAAGACAGGT CTCAGTTAAT 360
TTAGAAAGTT TATTTTGCCA AGGTTGAGGA CATGTGCCCG TGACACAGCT TTGTCACACA 420
GCCTCAGGAA GTTCTGATGA CATGTGCCCA AGGTGGTTGG GGCACAGTTT GGTTTTATAC 480
ATTTTAGGGA GACATGAGAC ATCAATCAAT ATATGTAAGA AGTACATTGG TTCCATCCAG 540
AAAGATGGGG ACAACTCAAA GCAGGGAAGG GGCTTCCAGG TCACAGGTAG GTAAGAGACA 600
AATGGTTGCA TTCTTTTGAG TTTCTGATTC TTTTCCAAAG GAGGCTATCA GATATGCATC 660
TATCTCAGTG AACAGAGGGA TGACTTTGAA TAGAATGGGA GGCAGGTTTG CCCTGAGTAG 720
TTCCCAGCTT GACTTTTCCC TTTAGCTTGG TGATTTTGAG GCCCCAAGAT TTTCCTTTCA 780
CAGACTCAGG ATGTCTTCTT CAGTTCAGGA TGGACAGCCT CAGAGTAGAG AGCTTCAGGC 840
CCCCTCTCCT TATCTTCTGC TAACCTCCAT TCTTACTCCT ACCCTTTCAT CTCAGAATTT 900
TCGCTTTGAT GTTTCCCACT TCCTTCCTAT GGTTACTTTA ACCGAAGTGA GTCAGGTCTT 960
ACTGAAAAAC TGACCACAGC CTGTCCGCTC CCAGCCTTCC CCAGACCAGG GCTGCCCAGG 1020
CAGAGCGTGA GGGGGACTAG TGTTTACTCA GCTCATTTTT TTCCTCCTCT CTCCTCTAAG 1080
TCACGGGGCT TTGAGTAGGG CTTCCCCAGC CACCGTGCCC CTCCCAGCAG ACCGCAGTCA 1140
GAAGCCAATC TCACATTTGT CTGGTGGCTC AGAGAGGGGA CAGAAAGAGC AGCAGCTTAT 1200
GTCCTTGGCT ATCCTCTCAA GTGGGCTAAT TTGCTTATTT TCAACTCTGT TGGGTCCAGC 1260
CCTGTTGCCT CTGATCTCAG CTCAAAGAGG ATTTGGCGGG AGTTTTTGGT TGTGATAACC 1320
AATAACAACC AACTATACGC ACTGCGAACA TCTCCTAGTG CCAGAAGCCC TGTTAGCTCA 1380
TTATCTTAAT CCTCAGGATA ACCCAGGCAA TTTGTATTCA CCCTAAAAAC TTCCCCTGGC 1440
CGGGTGTGGT GGCTCACGCC TGTAATCCCA GCAATTTGGG AGACTGAGGC AGGCGGATCA 1500
CTTGAGGCCA GGAGTTCCTA ACCAGCCTGG CCAACATGGT GAAACCCCAT CTGTACTAAA 1560
AATGCAAAAA ATTAGCCGGG CGTGGTGGCA CATGCCTGTA GTCCCAGCTA CTTGGGAGGC 1620
TGAGGCAGGA GAATCACTTG AACCTGGGAG GCGGAGGTTG CAGTGAGCTG AGATCATGCC 1680
ATTGCACTCC AGCCTGGAGA CAGGGCGAGA CTCCGTCTCG AAAAGCAACA ACAAAAACAA 1740
AAACAACCTC CAAAAAACCT TCCCCTGTTT ACCTTTCTAA TTTTGGTACC TACAGAATCT 1800
CCCCGTTAGC CTTGAAAATC AGCATGATCT TTAAGGATTT AGGAGCAAAT CTTTAAAGGA 1860
TTGAGTTGTG GGAAGACCAT GATGTCTTTG CTACTGGCTT TTGCAGTGAG AATAGCTTTT 1920
TCTCTGATCA GGTTTGGAGC CTTCCCTCTC TCCTGGGGGT AGGGGGTAGC TGGCTTCCTT 1980
TCTCTGAAAT GCAGAATTCA TTCACCCACT CTCTTTTGTC 2020
|
